Publication | Closed Access

Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344)

Metabolic SyndromeMedicinal ChemistryAnti-adipogenic EffectsBiochemistryMedicineNatural SciencesDiabetesPharmacological AgentMetabolic RegulationMetabolic RemodelingMetabolic SignalingPharmacologyDrug Discovery